Direct	direct	O	O
inhibition	inhibition	O	O
of	of	O	O
cardiac	cardiac	O	O
hyperpolarization-activated	hyperpolarization-activated	S_chemicals	O
cyclic	cyclic	O	O
nucleotide-gated	nucleotide-gated	O	O
pacemaker	pacemaker	B_chemicals	O
channels	channels	I_chemicals	O
by	by	O	O
clonidine	clonidine	S_chemicals	O
.	.	O	O

BACKGROUND	background	O	O
:	:	O	O
Inhibition	inhibition	O	O
of	of	O	O
cardiac	cardiac	O	O
sympathetic	sympathetic	O	O
tone	tone	O	O
represents	represents	O	O
an	an	O	O
important	important	O	O
strategy	strategy	O	O
for	for	O	O
treatment	treatment	O	O
of	of	O	O
cardiovascular	cardiovascular	O	B_disease
disease	disease	O	S_disease
,	,	O	O
including	including	O	O
arrhythmia	arrhythmia	O	S_disease
,	,	O	O
coronary	coronary	O	B_disease
heart	heart	O	B_disease
disease	disease	O	S_disease
,	,	O	O
and	and	O	O
chronic	chronic	O	O
heart	heart	O	B_disease
failure	failure	O	I_disease
.	.	O	O

Activation	activation	O	O
of	of	O	O
presynaptic	presynaptic	S_chemicals	S_disease
alpha2-adrenoceptors	alpha2-adrenoceptors	O	O
is	is	O	O
the	the	O	O
most	most	O	O
widely	widely	O	O
accepted	accepted	O	O
mechanism	mechanism	O	O
of	of	O	O
action	action	O	O
of	of	O	O
the	the	O	O
antisympathetic	antisympathetic	O	O
drug	drug	S_chemicals	O
clonidine	clonidine	S_chemicals	O
;	;	O	O
however	however	O	O
,	,	O	O
other	other	O	O
target	target	O	O
proteins	proteins	S_chemicals	O
have	have	O	O
been	been	O	O
postulated	postulated	O	O
to	to	O	O
contribute	contribute	O	O
to	to	O	O
the	the	O	O
in	in	O	O
vivo	vivo	O	O
actions	actions	O	O
of	of	O	O
clonidine	clonidine	S_chemicals	O
.	.	O	O

METHODS	methods	O	O
AND	and	O	O
RESULTS	results	O	O
:	:	O	O
To	to	O	O
test	test	O	O
whether	whether	O	O
clonidine	clonidine	S_chemicals	O
elicits	elicits	O	O
pharmacological	pharmacological	O	O
effects	effects	O	O
independent	independent	O	O
of	of	O	O
alpha2-adrenoceptors	alpha2-adrenoceptors	O	O
,	,	O	O
we	we	O	O
have	have	O	O
generated	generated	O	O
mice	mice	O	O
with	with	O	O
a	a	O	O
targeted	targeted	O	O
deletion	deletion	O	O
of	of	O	O
all	all	O	O
3	3	O	O
alpha2-adrenoceptor	alpha2-adrenoceptor	O	O
subtypes	subtypes	S_chemicals	O
(	(	O	O
alpha2ABC-/-	alpha2abc-/-	O	O
)	)	O	O
.	.	O	O

Alpha2ABC-/-	alpha2abc-/-	O	O
mice	mice	O	O
were	were	O	O
completely	completely	O	O
unresponsive	unresponsive	O	O
to	to	O	O
the	the	O	O
analgesic	analgesic	S_chemicals	O
and	and	O	O
hypnotic	hypnotic	B_chemicals	O
effects	effects	I_chemicals	O
of	of	O	O
clonidine	clonidine	S_chemicals	O
;	;	O	O
however	however	O	O
,	,	O	O
clonidine	clonidine	S_chemicals	O
significantly	significantly	O	O
lowered	lowered	O	O
heart	heart	O	O
rate	rate	O	O
in	in	O	O
alpha2ABC-/-	alpha2abc-/-	O	O
mice	mice	O	O
by	by	O	O
up	up	O	O
to	to	O	O
150	150	O	O
bpm	bpm	O	O
.	.	O	O

Clonidine-induced	clonidine-induced	O	O
bradycardia	bradycardia	O	S_disease
in	in	O	O
conscious	conscious	O	O
alpha2ABC-/-	alpha2abc-/-	O	O
mice	mice	O	O
was	was	O	O
32.3	32.3	O	O
%	%	O	O
(	(	O	O
10	10	O	O
microg/kg	microg/kg	O	O
)	)	O	O
and	and	O	O
26.6	26.6	O	O
%	%	O	O
(	(	O	O
100	100	O	O
microg/kg	microg/kg	O	O
)	)	O	O
of	of	O	O
the	the	O	O
effect	effect	O	O
in	in	O	O
wild-type	wild-type	O	O
mice	mice	O	O
.	.	O	O

A	a	O	O
similar	similar	O	O
bradycardic	bradycardic	O	O
effect	effect	O	O
of	of	O	O
clonidine	clonidine	S_chemicals	O
was	was	O	O
observed	observed	O	O
in	in	O	O
isolated	isolated	O	O
spontaneously	spontaneously	O	O
beating	beating	O	O
right	right	O	O
atria	atria	O	O
from	from	O	O
alpha2ABC-knockout	alpha2abc-knockout	O	O
and	and	O	O
wild-type	wild-type	O	O
mice	mice	O	O
.	.	O	O

Clonidine	clonidine	S_chemicals	O
inhibited	inhibited	O	O
the	the	O	O
native	native	O	O
pacemaker	pacemaker	O	O
current	current	O	O
(	(	O	O
I(f	i(f	O	O
)	)	O	O
)	)	O	O
in	in	O	O
isolated	isolated	O	O
sinoatrial	sinoatrial	O	S_disease
node	node	O	O
pacemaker	pacemaker	O	O
cells	cells	O	O
and	and	O	O
the	the	O	O
I(f)-generating	i(f)-generating	O	O
hyperpolarization-activated	hyperpolarization-activated	S_chemicals	O
cyclic	cyclic	O	O
nucleotide-gated	nucleotide-gated	O	O
(	(	O	O
HCN	hcn	S_chemicals	O
)	)	O	O
2	2	O	O
and	and	O	O
HCN4	hcn4	S_chemicals	O
channels	channels	O	O
in	in	O	O
transfected	transfected	O	O
HEK293	hek293	O	O
cells	cells	O	O
.	.	O	O

As	as	O	O
a	a	O	O
consequence	consequence	O	O
of	of	O	O
blocking	blocking	O	O
I(f	i(f	O	O
)	)	O	O
,	,	O	O
clonidine	clonidine	S_chemicals	O
reduced	reduced	O	O
the	the	O	O
slope	slope	O	O
of	of	O	O
the	the	O	O
diastolic	diastolic	O	O
depolarization	depolarization	O	O
and	and	O	O
the	the	O	O
frequency	frequency	O	O
of	of	O	O
pacemaker	pacemaker	O	O
potentials	potentials	O	O
in	in	O	O
sinoatrial	sinoatrial	O	S_disease
node	node	O	O
cells	cells	O	O
from	from	O	O
wild-type	wild-type	O	O
and	and	O	O
alpha2ABC-knockout	alpha2abc-knockout	O	O
mice	mice	O	O
.	.	O	O

CONCLUSIONS	conclusions	O	O
:	:	O	O
Direct	direct	O	O
inhibition	inhibition	O	O
of	of	O	O
cardiac	cardiac	O	O
HCN	hcn	B_chemicals	O
pacemaker	pacemaker	B_chemicals	O
channels	channels	I_chemicals	O
contributes	contributes	O	O
to	to	O	O
the	the	O	O
bradycardic	bradycardic	O	O
effects	effects	O	O
of	of	O	O
clonidine	clonidine	S_chemicals	O
gene-targeted	gene-targeted	O	O
mice	mice	O	O
in	in	O	O
vivo	vivo	O	O
,	,	O	O
and	and	O	O
thus	thus	O	O
,	,	O	O
clonidine-like	clonidine-like	O	O
drugs	drugs	S_chemicals	O
represent	represent	O	O
novel	novel	O	O
structures	structures	O	O
for	for	O	O
future	future	O	O
HCN	hcn	S_chemicals	O
channel	channel	B_chemicals	O
inhibitors	inhibitors	I_chemicals	O
.	.	O	O

